Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA — Although rare, hypercalcemia should be treated as a potential threat for patients with from ...
AR882 is an investigational selective uric acid transporter 1 inhibitor. The Food and Drug Administration (FDA) has granted Fast Track designation to AR882 for the treatment of clinically visible ...
Management of a patient allergic to allopurinol can be considered a therapeutic challenge. This article highlights the diversity of medications that can be used to manage hyperuricemia during this ...
Chronic tophaceous gout (CTG) is an independent risk factor for colorectal cancer (CRC), according to study results presented at Digestive Disease Week (DDW), held from May 6 to 9, 2023 in Chicago, ...
Please provide your email address to receive an email when new articles are posted on . Both excessive and long-term alcohol consumption, as well as any spirit consumption, predict the development of ...
Gout patients frequently have a number of comorbidities, including obesity, hypertension, high serum lipid and cholesterol levels, kidney disease, diabetes, and cardiovascular disease. [2,7,19–21] Due ...
STOCKHOLM, Feb. 9, 2026 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) Sobi® (STO: SOBI) and Arthrosi Therapeutics, Inc. (Arthrosi) announced today the completion of the acquisition of Arthrosi by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results